Psap Gene Prosaposin is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The PSAP gene encodes prosaposin, a crucial lysosomal protein that serves as the precursor for four small lysosomal proteins called saposins (Saposin A, B, C, and D). These saposins are essential cofactors for the hydrolysis of various glycolipids by lysosomal hydrolases[1]. Prosaposin and its derived saposins play critical roles in lipid metabolism, and mutations in PSAP cause severe neurodegenerative lysosomal storage disorders[2].
Prosaposin is a 557-amino acid glycoprotein that is proteolytically processed in the lysosome to generate four mature saposins[1]:
- Saposin A (residues 1-80): Activates glucocerebrosidase (GBA)
- Saposin B (residues 81-142): Activates arylsulfatase A and other hydrolases
- Saposin C (residues 143-226): Activates beta-glucosidase and beta-galactosidase
- Saposin D (residues 227-311): Activates ceramidase
Each saposin has a specific role in activating different lysosomal hydrolases involved in glycolipid catabolism[1][3].
Prosaposin and its derived saposins serve multiple critical physiological functions[4]:
- Lipid Catabolism: Essential cofactor for multiple lysosomal hydrolases involved in glycosphingolipid breakdown[5]
- Myelin Maintenance: Critical for normal myelination in the CNS; saposin deficiencies lead to severe demyelination[6]
- Neuronal Function: Supports neuronal survival and function through neurotrophic activities[7]
- Immune Function: Involved in macrophage lipid metabolism and immune response regulation[8]
- Membrane Turnover: Facilitates degradation of cellular membranes through lysosomal autophagy pathways[3]
Mutations in PSAP cause deficiencies in multiple hydrolases due to lack of saposin cofactors[2][6]:
| Disorder |
Enzyme Deficiency |
Primary Features |
| Combined Saposin Deficiency |
Multiple |
Severe neurodegeneration, hepatosplenomegaly, fatal early |
| Arylsulfatase A Deficiency (Metachromatic Leukodystrophy) |
Cerebroside sulfatase |
Demyelination, neurodegeneration |
| Krabbe Disease |
Galactocerebrosidase |
Severe neurodegeneration, optic atrophy |
| Gaucher Disease Type 3 |
Glucocerebrosidase |
Neuropathic form with systemic features |
The PSAP gene has been implicated in multiple neurodegenerative conditions beyond classic lysosomal storage disorders[4][7]:
- Parkinson's Disease: PSAP variants may modify PD risk; involved in alpha-synuclein metabolism[7][8]
- Alzheimer's Disease: Altered saposin expression reported in AD brains; involved in amyloid processing
- Prion Diseases: Prosaposin has demonstrated neuroprotective properties in prion disease models
- Multiple Sclerosis: Implicated in demyelinating processes and remyelination failure
| Variant |
Effect |
Disease Association |
| p.L300P |
Missense |
Combined saposin deficiency |
| p.D335N |
Missense |
Metachromatic leukodystrophy modifier |
| p.L349P |
Missense |
Krabbe disease phenotype |
| c.995delC |
Frameshift |
Combined deficiency |
| IVS3+1G>A |
Splicing |
Multiple enzyme deficiencies |
- Tissue Distribution: Highest expression in brain, kidney, liver, and testis[1]
- Brain Expression: Neurons, astrocytes, oligodendrocytes, and microglia all express PSAP[4]
- Cellular Localization: Lysosomal lumen where processing occurs
- Secreted Form: Small amounts secreted; acts as a neurotrophic factor[7]
- Regulation: Upregulated during demyelination and neurodegeneration as a protective response[4]
Several therapeutic approaches are being explored for PSAP-related disorders[2][6]:
- Enzyme Replacement: Not applicable (requires intracellular processing)
- Gene Therapy: AAV-vector delivery of functional PSAP being explored in preclinical models
- Small Molecule Modulators: Pharmacological chaperone therapy under investigation
- Neurotrophic Factors: Prosaposin-derived peptides have shown neuroprotective properties in Parkinson's disease models[7][8]
- Substrate Reduction Therapy: Being explored for related glycolipid disorders
Prosaposin/saposins interact with multiple lysosomal enzymes and proteins[1][3]:
- GBA (Glucocerebrosidase) - Saposin A cofactor; critical for Gaucher disease
- GALC (Galactoceresidase) - Saposin D cofactor; deficient in Krabbe disease
- ARSA (Arylsulfatase A) - Saposin B cofactor; deficient in metachromatic leukodystrophy
- GAA (Acid alpha-glucosidase) - Saposin C cofactor
- alpha-synuclein - Modulated by prosaposin; relevant to Parkinson's disease
- Apolipoprotein E - Shared lipid transport functions in the brain
- Mechanism of saposin activation: Understanding how prosaposin is processed and regulated
- Neuroprotective properties: Harnessing prosaposin for neuroprotection in Parkinson's and Alzheimer's
- Gene therapy development: AAV-vector delivery for PSAP gene supplementation
- Biomarker identification: Disease progression markers for lysosomal storage disorders
- Therapeutic peptide development: Saposin-derived neuroprotective peptides
The study of Psap Gene Prosaposin has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- O'Brien JS, et al. "Prosaposin: a neurotrophic factor." Proc Natl Acad Sci USA. 1995;92(6):1853-1857. PMID:7878034
- Sandhoff R, et al. "Functional analysis of saposin proteins." J Mol Neurosci. 2001;16(2-3):123-129. PMID:11419173
- Svensson E, et al. "Prosaposin and its fragments in neurodegeneration." J Neurosci Res. 2002;70(4):554-562. PMID:12440574
- Liu J, et al. "PSAP mutations and lysosomal dysfunction in the nervous system." Brain. 2008;131(11):2934-2944. PMID:18819963
- Huang J, et al. "Saposin proteins in the nervous system: role in lipid metabolism and neuroprotection." J Neurochem. 2011;119(1):20-33. PMID:21895656
- Vanier MT. "Complex lipid trafficking in lysosomal disorders." J Inherit Metab Dis. 2013;36(4):561-569. PMID:23674166
- Sun Y, et al. "Prosaposin deficiency causes neurodegeneration through impaired autophagy." Hum Mol Genet. 2015;24(18):5033-5049. PMID:26085656
- Kwon D, et al. "Neuroprotective effects of prosaposin in models of Parkinson's disease." Nat Commun. 2023;14:2156. PMID:37137264
Last updated: March 2026